Canada News

Canadian News and
Press Release Distribution Services
Home | Submit Press Release
Unlimited Press Release Distribution
Press release distribution service

News Media

Abitibi-Témiscamingue
Business Vancouver
Canoe-ca
Canada News Center
Daily Herald Tribune
Canada.Com
CTVNews
La Press
National Post
The Globe and Mail
The Province
The Star
The Gazette
Toronto Sun
Yahoo! Canada

Canada Business News and Press Releases

Global Autoimmune Monoclonal Antibodies market worth USD 17,329.5 million

 



(EMAILWIRE.COM, February 09, 2018 ) Global Autoimmune Monoclonal Antibodies market is expected to reach USD 25,274.7 million by 2022 from USD 17,329.5 million in 2017, growing at a CAGR of 7.84% during forecast period 2017-2022. Irregular functioning of humans’ immune system results in autoimmune disorders. Overproduction of self-reactive immune cells (such as antibodies & T-cells) damage regular functions of /cells/tissues/organs. This lead to different autoimmune disorders such as systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, and others diseases. Typically, drugs are used as a treatment to cure autoimmune disorders. The adverse effects associated with drugs has made switched to concentrate on monoclonal antibodies.



Monoclonal antibodies have the ability to offer less toxic and more efficient therapeutic alternatives to treat autoimmune diseases. Recent years have seen the emergence of monoclonal antibodies being used to treat wide array of diseases that are related to immune response. These antibodies are mono-specific comprising of identical immune cells which are clones of a single parent cell and are directed towards a specific cellular target. Thus monoclonal antibodies due to its customizable nature can be used to treat the self-reactive immune cells not impacting the normal ones.



View full report @ https://www.marketdataforecast.com/market-reports/global-autoimmune-monoclonal-antibodies-1170/



Growing research & development to stimulate the development of monoclonal antibodies rising number of patients with autoimmune diseases, and increasing public & private organizations involvement to support advanced therapeutics development are driving the growth of global autoimmune monoclonal antibodies market. In addition, rising demand for antibody based therapeutics, increasing adoption of advanced healthcare therapeutics, and growing number of lifestyle associated disorders are further promoting the growth of global autoimmune monoclonal antibodies. However, presence of stringent regulatory pathways, lack of advanced research facilities & underdeveloped healthcare infrastructure in certain developing regions, and limited accessibility of monoclonal antibodies therapeutics due to high cost are restraining the growth of autoimmune monoclonal antibodies.



Market Segmentation:

1 By Source

1.1 Murine

1.2 Chimeric

1.3 Humanized

1.4 Human



2 By Application

2.1 Systemic Lupus Erythematosus

2.2 Rheumatoid Arthritis

2.3 Multiple Sclerosis

2.4 Transplant Rejection/Graft Versus Host Disease

2.5 Others



3 End User

3.1 Hospitals/Clinics

3.2 Research Institute

3.3 Diagnostic Laboratories





Global Autoimmune Monoclonal Antibodies market is segmented based on source, application, and end user. Based on source, the market is further sub-segmented as Murine, Chimeric, Humanized, and Human. Among these, humanized segment is expected to command the largest share in Global Autoimmune Monoclonal Antibodies market, by source in 2016. Based on application, the market is further segmented as Systemic Lupus Erythematosus, Rheumatoid Arthritis, Multiple Sclerosis, Transplant Rejection/Graft Versus Host Disease, and Others. Of these, rheumatoid arthritis application is anticipated to command the major share in Global Autoimmune Monoclonal Antibodies market, by application in 2016. Based on end user, the market is further segmented as Hospitals/Clinics, Research Institutes, and Diagnostic Laboratories. Among these, Hospitals/Clinics segment is expected to hold the major market share in Global Autoimmune Monoclonal Antibodies market, by application in 2016.



Get free sample report @ https://www.marketdataforecast.com/market-reports/global-autoimmune-monoclonal-antibodies-1170/request-sample



On the basis of geographical region the global Autoimmune Monoclonal Antibodies market is segmented as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America is expected to command the major market share of 45.0% of the global Autoimmune Monoclonal Antibodies market in 2017 and expected to grow at the highest CAGR of 8.47% during the forecast period 2017-2022.

The key players in global Autoimmune Monoclonal Antibodies market include, GlaxoSmithKline plc (U.K.), AstraZeneca plc (U.K.), F. Hoffmann-La Roche Ltd. (Switzerland), Bristol-Myers Squibb (U.S.), Johnson & Johnson (U.S.), Innovent Biologics, Inc. (China), Takeda Pharmaceutical Company Ltd. (Japan), Amgen Inc. (U.S.), Biogen Inc.(U.S.), and UCB Company (Belgium).


About Market Data Forecast
Market Data Forecast is a well versed market research firm catering solutions in the fields of market research, business intelligence and consulting. With a profound knowledge about the global market activities coupled with a customized approach. We render services in the most gripping markets like healthcare, agriculture and food & Beverages

More about Market Data Forecast

Market Data Forecast

Abhishek Shukla

9985550206

abhishek@marketdataforecast.com

Source: EmailWire.Com


Canada News by Regions
  • Atlantic Canada
  • Calgary
  • Edmonton
  • Halifax
  • Montreal
  • Ottawa
  • Quebec
  • Toronto
  • Vancouver
  • Winnipeg


  • 
    
    
    

    Meeting and Travel
    We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Meetings & Travel resource center today to browse our selection of 600+ complimentary Meetings & Travel magazines, white papers, webinars, podcasts, and more. Get popular titles including:

    Group Tour Magazine
    Event Design
    Insite from Leisure Group Travel

    No credit cards, coupons, or promo codes required. Try it today!

    EmailWire.com - Press release service
    Press release distribution service

    For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com.
    Copyright 2009 GroupWeb Media LLC

    GroupWeb Media Network
    AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
    | InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
    I-Canada-News.com - I-Canada-News.Com is a news service of GroupWeb Media LLC